Cases & Deals

Maverick Capital affiliates re-invest in Nodality

Clients Maverick Capital Ltd.

Jones Day advised affiliates of Maverick Capital Ltd. in connection with their purchase of Series B Preferred Stock in an expected $10 million private placement by Nodality, Inc., a biotechnology company developing next generation personal diagnostics focused on cell pathways. Co-investors include Kleiner Perkins Caufield & Byers and TPG Biotechnology.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.